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A 60-year-old obese male patient was admit-
ted to the coronary care unit complaining of typi-
cal angina (CCS4). The patient’s history included 
chronic renal failure and subsequent kidney trans-
plantation, long-term hypertension, and coronary 
artery disease. In 1990, he underwent surgical 
revascularization, where 3 venous grafts to left 
artery descending (LAD), circumflex artery (Cx), 
and right coronary artery were implanted. After 
13 years the patient was referred for a complex 
percutaneous coronary intervention (PCI) includ-
ing bare-metal stent (BMS) implantation to Cx, 
marginal branch and saphenous graft to LAD. At 
presentation, standard electrocardiogram revealed 
no new abnormalities with troponin T of 0.1 ng/mL. 
Echocardiography showed a pathological extracar-
diac structure adjacent to the left ventricle anterior 
wall (Fig. 1A, B). The subsequent angiography 
revealed a significant multivessel disease com-
prising a severe stenosis of the distal portion of 
Cx and a giant (80 × 50 mm) saphenous venous-
graft aneurysm (SVGA) to LAD with intramural 
thrombus formations, in-stent restenosis, and 
preserved Thrombolysis in Myocardial Infarc-
tion grade 3 flow (Fig. 1C). Three-dimentional 
computed tomography angiography (CTA) (Fig. 1D) 
and exercise-induced myocardial ischemia with 
Tc-99m sestamibi single-photon emission com-
puted tomography were performed for the purpose 
of precise structural evaluation of the venous 
graft and myocardial perfusion in the area of LAD, 
respectively. Considering the high risk of re-
operation and no substantial anterior wall ischemia 
the patient was offered a percutaneous treatment 
of Cx. The PCI and subsequent BMS implantation 
was performed with an excellent final result. After 
the procedure, the patient remained asymptomatic 
and discharged home in a good clinical condition. 
The long-term follow-up was uneventful.
Aneurysmal dilatation of saphenous vein graft 
remains an extremely rare surgical complication 
after coronary artery by-pass graft procedure. 
Although no screening guideline related to the 
aortocoronary SVGA exists, the incidence has 
been ascertained to be around 0.07% in a single 
center experience. In several cases, the symptoms 
of myocardial ischemia were documented owing to 
a distal embolization, fistula drainage, mass effect 
in the native vessel, or even rupture resulting in 
hemodynamic compromise [1–4]. Nevertheless, 
SVGAs, by their asymptomatic course, seem to 
be underdiagnosed and are mainly identified acci-
dentally on imaging [5]. Previously, patients with 
SVGAs were referred for surgical strategy. With 
refinement of percutaneous techniques, treatment 
strategies in patients with SVGAs are diverse, 
comprising, implantation of Amplatzer device, 
stentgrafts, and arterial coils [6]. Recently, several 
novel techniques have been described, including 
the transluminal reconstruction, to seal the aneu-
rysm and restore distal flow [7–10]. Since there is 
no consensus on the optimal approach in patients 
with SVGA, Ramirez et al. [6] proposed manage-
ment algorithm identifying individuals best suited 
for percutaneous or surgical treatment strategy [3]. 
There is no doubt that all these patients, if pos-
sible, should be assessed by the heart-team. The 
first step in deciding on management options for 
SVGAs is to assess for the presence of mechanical 
complications and/or other surgical indication. In 
cases with patent SVGAs and suitable anatomy, 
percutaneous management with a covered stent 
intervention/valvular heart disease
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should be pursued [3]. Multimodality imaging is 
often required to establish the size of the SVGA 
and the area supplied by affected graft [11]. Last 
but not least, the assessment of clinical symptoms 
and myocardial viability plays a key role in this 
diverse setting.
What sets our this case apart from most other 
ones is the fact of recording an unusual size of aneu-
rysm, which sometimes can be hardly distinguished 
from pseudoaneurysm, even on the CTA scans. 
Any surgical intervention on a degenerated bypass 
was exposed to unreasonable risk of a massive 
intraoperative bleeding. Thus, since the imaging 
examination did not reveal any essential ischemia 
of the anterior wall, to avoid reoperation in this 
high-risk patient, conservative management was 
sought, following heart team discussion achieving 
a satisfactory long-tem clinical result.
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Figure 1. A giant aorta (AO)-left artery descending graft aneurysm demonstrated by transthoracic echocardiography 
(A, B), angiography (C, arrow) and three-dimensional computed tomography angiography (D, arrow); ANEU — aneu-
rysm; LA — left atrium; LV — left ventricle; MV — mitral valve; LVOT — left ventricular outflow tract; RVOT — right 
ventricular outflow tract; PA — pulmonary artery.
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